TherapeuticsMD swings to Q3 profit, license revenue climbs

TherapeuticsMD

12/11/2025 21:24

Overview

TherapeuticsMD reports Q3 net income from cont ops of $50,000 compared to loss of $567,000 last year

License revenue for Q3 rises due to changes in sales of licensed products

Company exploring strategic alternatives, no assurance of transaction outcome

Outlook

TherapeuticsMD is evaluating strategic alternatives, including mergers or asset sales

Company has not set a timetable for strategic evaluations

Result Drivers

LICENSE REVENUE INCREASE - License revenue rose due to changes in sales of licensed products

OPERATING EXPENSES - Operating expenses decreased by 2.1% compared to Q3 2024

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Net Income from Cont Ops
$50,000
Q3 Operating Expenses
$1.65 mln


Press Release: ID:nBw8Hlscxa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)